Latest Breaking News On - Zenas biopharma - Page 10 : comparemela.com

Investegate |Zenas BioPharma Announcements | Zenas BioPharma: Zenas BioPharma Appoints Simon Lowry, M D as Chief Medical Officer

Investegate announcements from Zenas BioPharma, Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer

United kingdomZenas biopharmaSimon lowryTrinity hallCambridge universityCambridge university school of clinical medicineGlobal medical affairs franchise headRoivant sciencesOncology medical affairs group leaderZenas biopharma appoints simon lowryChief medicalChief executive officerChief medical officerKinevant scienceSun pharma north americaVice president

Zenas BioPharma Appoints Simon Lowry, M D as Chief Medical Officer | Comunicados | Edición USA

Zenas BioPharma Appoints Simon Lowry, M D as Chief Medical Officer | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

United kingdomZenas biopharmaSimon lowryTrinity hallCambridge universityCambridge university school of clinical medicineGlobal medical affairs franchise headRoivant sciencesOncology medical affairs group leaderZenas biopharma appoints simon lowryChief medicalChief executive officerChief medical officerKinevant scienceSun pharma north americaVice president

Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesZenas biopharmaNational medical products administrationViridian therapeutics incInvestigational new drugThyroid eye diseaseChief executive officerViridian therapeuticsDrug administrationNorth americaMedia contactGlobe newswire

Zenas BioPharma Obtains IND Approval in China for Phase 1/2

WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader.

United statesZenas biopharmaNational medical products administrationViridian therapeutics incInvestigational new drugThyroid eye diseaseChief executive officerViridian therapeuticsDrug administrationNorth americaMedia contactZenas biopharma usa llc

Investegate |Zenas BioPharma Announcements | Zenas BioPharma: Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease

Investegate announcements from Zenas BioPharma, Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease

United statesUnited kingdomZenas biopharmaNational medical products administrationViridian therapeutics incZenas biopharma obtainsThyroid eye diseaseInvestigational new drugChief executive officerViridian therapeuticsDrug administrationNorth americaMedia contactInvestegate announcementsInvestegate company announcementsZenas biopharma